Pentadecapeptide studied for angiogenesis and tendon-to-bone repair. The most-cited peptide in recovery research.
Synthetic fragment of thymosin beta-4. Studied for cell migration and tissue regeneration. Frequently stacked with BPC-157.
Lys-Pro-Val tripeptide derived from α-MSH. Studied for inflammatory pathways in IBD and skin models.
Triple agonist (GLP-1 / GIP / glucagon). Phase 2 trial: 24.2% mean weight reduction at 12 mg over 48 weeks.
Dual GLP-1 / GIP agonist. SURMOUNT-1 trial: 20.9% mean weight reduction at 15 mg.
GLP-1 receptor agonist. Phase 3 STEP-1: 15-17% mean weight loss over 68 weeks.
Long-acting amylin analog. Studied paired with GLP-1 for enhanced weight-loss effect (CagriSema).
HGH fragment 176-191. Studied for lipolysis signaling isolated from HGH's growth and glucose effects.
Selective ghrelin receptor agonist. Clean side-effect profile — minimal cortisol or prolactin elevation.
Bioidentical fragment of endogenous GHRH (residues 1-29). Long track record, short half-life.
Long-acting GHRH analog. FDA-approved (as Egrifta) for HIV-associated lipodystrophy.
Short-acting GHRH analog, without the albumin-binding DAC modification. Studied for pulsatile GH release.
The classic GH-secretagogue pairing in one vial — a short-acting GHRH analog plus a selective ghrelin agonist, 5 mg of each.
Ala-Glu-Asp-Gly tetrapeptide from the pineal gland. Studied for telomerase activity in cellular aging models.
Central coenzyme in sirtuin activation and DNA repair pathway signaling.
16-amino-acid peptide encoded within mitochondrial DNA. Studied for insulin sensitivity and metabolic homeostasis.
The body's master antioxidant tripeptide. Studied for oxidative-stress reduction and phase-II detoxification pathways.
Mitochondria-targeted tetrapeptide (Elamipretide). Binds cardiolipin, studied for bioenergetics and oxidative stress.
Synthetic analog of ACTH fragment 4-10. Studied for cognitive endurance and BDNF expression.
Delta sleep-inducing peptide. Studied for sleep architecture and cortisol regulation.
Endogenous nonapeptide. Studied for cortisol regulation and stress-response research.
Proprietary multi-peptide blend formulated around dermatological pathways relevant to skin research.
Octapeptide extension of Argireline. Studied for effects on muscle-contraction signaling relevant to expression lines.
Melanocortin receptor agonist (bremelanotide). FDA-approved for hypoactive sexual desire disorder in women.
Master regulator of the hypothalamic-pituitary-gonadal axis. Studied for GnRH release and libido-related pathways.
Copper-binding tripeptide. Studied for collagen synthesis, wound-healing signaling, and skin remodeling.
Synthetic α-MSH analog. Studied for melanogenesis and, via MC4R, libido-related pathways.
Copper-binding tripeptide related to GHK-Cu. Studied for antioxidant activity and skin-regeneration signaling.